2
Jun
2026

F.I.S. Fabbrica Italiana Sintetici SpA

Exhibitor at CPHI Americas 2026 stand 1424
About Us

FIS is one of the CDMO leaders in Europe for small molecule APIs & Intermediates, driving innovation in drug development and production

Founded in 1957 in Montecchio Maggiore (VI) and now controlled by the private equity fund Bain Capital, FIS has been partnering with the world's leading pharmaceutical companies for 70 years in the development and production of active pharmaceutical ingredients (APIs). With over 2,300 employees in Italy across three sites, offices in North America and Japan and an operational pres...

  • Country/Region:
    Italy
  • Founded:
    1957
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
  • Viale Milano 26, 36075, Montecchio Maggiore (Vicenza), Italy
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1424

Products Featured at CPHI Americas 2026

  • Nitrofurantoin macrocrustals and monohydrate

    Product Nitrofurantoin macrocrustals and monohydrate

    FIS produces a wide range of API's which includes Nitrofurantoin macrocrystals and monohydrate. It is commercially available. Contact us for more information:[email protected]
  • Diazepam

    Product Diazepam

    FIS produces a wide range of API's which includes Diazepam. It is commercially available. Contact us for more information:[email protected]
  • Furosemide

    Product Furosemide

    FIS produces a wide range of API's which includes Furosemide. It is commercially available. Contact us for more information:[email protected]
  • Bromazepam

    Product Bromazepam

    FIS produces a wide range of API's which includes Bromazepam. It is commercially available. Contact us for more information:
    [email protected]